169 related articles for article (PubMed ID: 23031260)
1. Human multipotent adult progenitor cells are nonimmunogenic and exert potent immunomodulatory effects on alloreactive T-cell responses.
Jacobs SA; Pinxteren J; Roobrouck VD; Luyckx A; van't Hof W; Deans R; Verfaillie CM; Waer M; Billiau AD; Van Gool SW
Cell Transplant; 2013; 22(10):1915-28. PubMed ID: 23031260
[TBL] [Abstract][Full Text] [Related]
2. Mutual interaction between human multipotent adult progenitor cells and NK cells.
Jacobs SA; Plessers J; Pinxteren J; Roobrouck VD; Verfaillie CM; Van Gool SW
Cell Transplant; 2014; 23(9):1099-110. PubMed ID: 23562064
[TBL] [Abstract][Full Text] [Related]
3. Clinical-Grade Human Multipotent Adult Progenitor Cells Block CD8+ Cytotoxic T Lymphocytes.
Plessers J; Dekimpe E; Van Woensel M; Roobrouck VD; Bullens DM; Pinxteren J; Verfaillie CM; Van Gool SW
Stem Cells Transl Med; 2016 Dec; 5(12):1607-1619. PubMed ID: 27465071
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow-derived conventional, but not cloned, mesenchymal stem cells suppress lymphocyte proliferation and prevent graft-versus-host disease in rats.
Kitazawa Y; Li XK; Xie L; Zhu P; Kimura H; Takahara S
Cell Transplant; 2012; 21(2-3):581-90. PubMed ID: 22793067
[TBL] [Abstract][Full Text] [Related]
5. Differentiation potential of human postnatal mesenchymal stem cells, mesoangioblasts, and multipotent adult progenitor cells reflected in their transcriptome and partially influenced by the culture conditions.
Roobrouck VD; Clavel C; Jacobs SA; Ulloa-Montoya F; Crippa S; Sohni A; Roberts SJ; Luyten FP; Van Gool SW; Sampaolesi M; Delforge M; Luttun A; Verfaillie CM
Stem Cells; 2011 May; 29(5):871-82. PubMed ID: 21433224
[TBL] [Abstract][Full Text] [Related]
6. Ex vivo immunosuppressive effects of mesenchymal stem cells on Crohn's disease mucosal T cells are largely dependent on indoleamine 2,3-dioxygenase activity and cell-cell contact.
Ciccocioppo R; Cangemi GC; Kruzliak P; Gallia A; Betti E; Badulli C; Martinetti M; Cervio M; Pecci A; Bozzi V; Dionigi P; Visai L; Gurrado A; Alvisi C; Picone C; Monti M; Bernardo ME; Gobbi P; Corazza GR
Stem Cell Res Ther; 2015 Jul; 6(1):137. PubMed ID: 26206376
[TBL] [Abstract][Full Text] [Related]
7. Immunomodulatory effects of stem cells.
Wada N; Gronthos S; Bartold PM
Periodontol 2000; 2013 Oct; 63(1):198-216. PubMed ID: 23931061
[TBL] [Abstract][Full Text] [Related]
8. Placenta-derived multipotent cells exhibit immunosuppressive properties that are enhanced in the presence of interferon-gamma.
Chang CJ; Yen ML; Chen YC; Chien CC; Huang HI; Bai CH; Yen BL
Stem Cells; 2006 Nov; 24(11):2466-77. PubMed ID: 17071860
[TBL] [Abstract][Full Text] [Related]
9. Oct4-negative multipotent adult progenitor cells and mesenchymal stem cells as regulators of T-cell alloreactivity in mice.
Luyckx A; De Somer L; Jacobs S; Rutgeerts O; Lenaerts C; Roobrouck VD; Verfaillie CM; Waer M; Van Gool SW; Billiau AD
Immunol Lett; 2011 Jun; 137(1-2):78-81. PubMed ID: 21382417
[TBL] [Abstract][Full Text] [Related]
10. Immunosuppressive CD14+HLA-DRlow/neg IDO+ myeloid cells in patients following allogeneic hematopoietic stem cell transplantation.
Mougiakakos D; Jitschin R; von Bahr L; Poschke I; Gary R; Sundberg B; Gerbitz A; Ljungman P; Le Blanc K
Leukemia; 2013 Feb; 27(2):377-88. PubMed ID: 22828446
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of T-cell proliferation by murine multipotent mesenchymal stromal cells is mediated by CD39 expression and adenosine generation.
Sattler C; Steinsdoerfer M; Offers M; Fischer E; Schierl R; Heseler K; Däubener W; Seissler J
Cell Transplant; 2011; 20(8):1221-30. PubMed ID: 21176405
[TBL] [Abstract][Full Text] [Related]
12. Human but not murine multipotent mesenchymal stromal cells exhibit broad-spectrum antimicrobial effector function mediated by indoleamine 2,3-dioxygenase.
Meisel R; Brockers S; Heseler K; Degistirici O; Bülle H; Woite C; Stuhlsatz S; Schwippert W; Jäger M; Sorg R; Henschler R; Seissler J; Dilloo D; Däubener W
Leukemia; 2011 Apr; 25(4):648-54. PubMed ID: 21242993
[TBL] [Abstract][Full Text] [Related]
13. Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells.
Krampera M; Cosmi L; Angeli R; Pasini A; Liotta F; Andreini A; Santarlasci V; Mazzinghi B; Pizzolo G; Vinante F; Romagnani P; Maggi E; Romagnani S; Annunziato F
Stem Cells; 2006 Feb; 24(2):386-98. PubMed ID: 16123384
[TBL] [Abstract][Full Text] [Related]
14. Activated T cells modulate immunosuppression by embryonic-and bone marrow-derived mesenchymal stromal cells through a feedback mechanism.
Lin W; Oh SK; Choo AB; George AJ
Cytotherapy; 2012 Mar; 14(3):274-84. PubMed ID: 22136295
[TBL] [Abstract][Full Text] [Related]
15. Requirement of IFN-gamma-mediated indoleamine 2,3-dioxygenase expression in the modulation of lymphocyte proliferation by human adipose-derived stem cells.
DelaRosa O; Lombardo E; Beraza A; Mancheño-Corvo P; Ramirez C; Menta R; Rico L; Camarillo E; García L; Abad JL; Trigueros C; Delgado M; Büscher D
Tissue Eng Part A; 2009 Oct; 15(10):2795-806. PubMed ID: 19231921
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity and immunomodulatory properties of umbilical cord lining mesenchymal stem cells.
Deuse T; Stubbendorff M; Tang-Quan K; Phillips N; Kay MA; Eiermann T; Phan TT; Volk HD; Reichenspurner H; Robbins RC; Schrepfer S
Cell Transplant; 2011; 20(5):655-67. PubMed ID: 21054940
[TBL] [Abstract][Full Text] [Related]
17. Immunomodulatory properties of porcine, bone marrow-derived multipotent mesenchymal stromal cells and comparison with their human counterpart.
Comite P; Cobianchi L; Avanzini MA; Mantelli M; Achille V; Zonta S; Ferrari C; Alessiani M; De Silvestri A; Gandolfo GM; Inverardi L; Brescia L; Pietrabissa A; Dionigi P; Locatelli F; Bernardo ME
Cell Mol Biol (Noisy-le-grand); 2011 Oct; 57 Suppl():OL1600-5. PubMed ID: 22000490
[TBL] [Abstract][Full Text] [Related]
18. Immunosuppression by placental indoleamine 2,3-dioxygenase: a role for mesenchymal stem cells.
Jones BJ; Brooke G; Atkinson K; McTaggart SJ
Placenta; 2007; 28(11-12):1174-81. PubMed ID: 17714779
[TBL] [Abstract][Full Text] [Related]
19. Clinical scale expanded adult pluripotent stem cells prevent graft-versus-host disease.
Kovacsovics-Bankowski M; Streeter PR; Mauch KA; Frey MR; Raber A; van't Hof W; Deans R; Maziarz RT
Cell Immunol; 2009; 255(1-2):55-60. PubMed ID: 19022422
[TBL] [Abstract][Full Text] [Related]
20. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
